MedPath

Atos Medical AB

🇸🇪Sweden
Ownership
-
Employees
-
Market Cap
-
Website

Short-term Clinical Feasibility of the New Provox Vega 22.5 Voice Prosthesis

Phase 1
Completed
Conditions
Total Laryngectomy
Interventions
Device: Provox voice prosthesis
First Posted Date
2008-08-28
Last Posted Date
2023-07-25
Lead Sponsor
Atos Medical AB
Target Recruit Count
15
Registration Number
NCT00743262
Locations
🇳🇱

Netherlands Cancer Institute, Amsterdam, Noord Holland, Netherlands

Long-term Clinical Feasibility of the New Indwelling Provox Vega 20 Voice Prosthesis

Not Applicable
Terminated
Conditions
Total Laryngectomy
Interventions
Device: Provox Vega voice prosthesis (20 Fr)
First Posted Date
2008-04-18
Last Posted Date
2017-03-10
Lead Sponsor
Atos Medical AB
Target Recruit Count
26
Registration Number
NCT00661570
Locations
🇳🇱

Netherlands Cancer Institute, Amsterdam, Noord-Holland, Netherlands

© Copyright 2025. All Rights Reserved by MedPath